BRIXADI is indicated for the treatment of reasonable to severe opioid use condition in patients who've initiated treatment with one dose of the transmucosal buprenorphine product or service or who are by now staying treated with buprenorphine.Individuals that use heroin could become tolerant from the drug. This suggests they can need larger or even… Read More